A survey of 208 German CBD consumers found most were female (66%), aged 41–60, using CBD oil daily for over 3 months, with the majority reporting health-promoting effects — though the unregulated market raises quality concerns.
Regulators, pharmacists, healthcare providers counseling patients about OTC CBD, and CBD consumers.
What the researchers found
208 CBD consumers in Germany participated. The population was predominantly female (66%), aged 41–60 (46%), and chronic users (>3 months, at least daily). The principal mode was oil (36%). Consumers reported various health-promoting and therapeutic effects, with reasons for use spanning pain, sleep, anxiety, and general wellness.
Why it matters
Over-the-counter CBD is a massive and growing market, but consumer data about who is using it, why, and what effects they experience is surprisingly sparse. This German survey provides real-world consumer insights that can inform regulatory and clinical guidance.
The numbers in context
208 participants. 66% female. 46% aged 41–60. Chronic users (>3 months, daily minimum). Primary route: oil (36%). Recruited Feb–June 2023 via social media. Health-promoting effects reported by majority.
How the study worked
Explorative retrospective online survey accessible February–June 2023 via SoSci-Survey. Participants (n=208) recruited mainly through social internet platforms. Assessed reasons for consumption, health-promoting or therapeutic effects, and adverse effects.
What this study cannot tell us
Self-selected online sample recruited via social media — significant selection bias toward engaged CBD advocates. Small sample (n=208). Retrospective self-report of health effects. No verification of product contents or quality. German market context may differ from other countries.
How to read the evidence
Exploratory online survey with self-selected sample, providing useful descriptive data but with significant selection bias.
When this study was published
Published 2025, data from February–June 2023.
The bigger picture
The CBD consumer population is predominantly middle-aged women using products daily for chronic conditions — a demographic profile that differs from recreational cannabis users. Understanding this helps healthcare providers engage with patients who are likely already using CBD without medical guidance.
Questions still open
- Are consumers using products with accurate CBD content and no contaminants? Would physician-guided CBD use produce better outcomes than self-directed use? How do German OTC CBD consumers compare to those in other markets?
Common questions
Who is using over-the-counter CBD in Germany?
Do OTC CBD products actually work?
Read the original research
Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects.
Frontiers in pharmacology, 16, 1571025
Citation
Weissgerber, Anaelle; Hermanns-Clausen, Maren; Lamy, Evelyn. (2025). Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects.. Frontiers in pharmacology, 16, 1571025. https://doi.org/10.3389/fphar.2025.1571025
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk